BCAX vs CLYM: stock comparison and AI forecast
Bicara Therapeutics Inc. (BCAX) and Climb Bio, Inc. (CLYM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BCAX Bicara Therapeutics Inc.
- Price
- $8.96 -61.3% · 6M
- Market Cap
- $593M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CLYM Climb Bio, Inc.
- Price
- $9.75 -14.8% · 6M
- Market Cap
- $560M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- BCAX and CLYM have similar market capitalizations ($593M and $560M).
- Over the last six months CLYM returned -14.8% and BCAX -61.3%.
- BCAX carries 0.09 times debt per unit of equity, against 0.03 times for CLYM.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BCAX | CLYM |
|---|---|---|
| Market Cap | $593M | $560M |
| P/B Ratio | 1.26x | 2.34x |
| EPS | $-2.84 | $-0.93 |
| Book Value/Share | $7.08 | $4.17 |
| FCF/Share | $-2.04 | – |
Profitability & Margins
| Metric | BCAX | CLYM |
|---|---|---|
| ROE | -39.5% | -24.1% |
| ROA | -36.2% | -23.4% |
| ROIC | -43.1% | -26.9% |
| Tax Rate | -0.1% | 0.0% |
Financial Health
| Metric | BCAX | CLYM |
|---|---|---|
| Current Ratio | 11.59x | 31.45x |
| D/E Ratio | 0.09x | 0.03x |
| Financial Leverage | 1.09x | 1.03x |
| Working Capital | $460M | $181M |
Cash Flow
| Metric | BCAX | CLYM |
|---|---|---|
| Operating Cash Flow | -$135M | -$53M |
| Free Cash Flow | -$135M | – |
| Capital Spending | -$400K | – |
Income Statement
| Metric | BCAX | CLYM |
|---|---|---|
| Operating Income | -$202M | -$65M |
| Net Income | -$185M | -$58M |
| R&D Expense | $140M | $42M |
Dividend & Shareholder Information
| Metric | BCAX | CLYM |
|---|---|---|
| Shares Outstanding | 66M | 57M |
| EPS Growth | – | -720.0% |
BCAX vs CLYM: stock comparison and AI forecast
Which is bigger, BCAX or CLYM?
BCAX and CLYM have similar market capitalizations ($593M and $560M).
Which stock performed better over the last six months, BCAX or CLYM?
Over the last six months CLYM returned -14.8% and BCAX -61.3%.
Which one does Intratio's AI model rank higher, BCAX or CLYM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.